Ownership history in Mariner, LLC · 15 quarters on record
This page tracks every 13F SEC filing in which Mariner, LLC reported a position in RECURSION PHARMACEUTICALS IN (RXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 93,581 | +5,297 | +6.0% | 0.00% | $457K | $4.88 |
| 2025 Q2 | REDUCED | 88,284 | -19,457 | -18.1% | 0.00% | $447K | $5.06 |
| 2025 Q1 | REDUCED | 107,741 | -3,322 | -3.0% | 0.00% | $570K | $5.29 |
| 2024 Q4 | ADDED | 111,063 | +27,499 | +32.9% | 0.00% | $751K | $6.76 |
| 2024 Q3 | ADDED | 83,564 | +2,469 | +3.0% | 0.00% | $551K | $6.59 |
| 2024 Q2 | ADDED | 81,095 | +1,192 | +1.5% | 0.00% | $608K | $7.50 |
| 2024 Q1 | ADDED | 79,903 | +52 | +0.1% | 0.00% | $797K | $9.97 |
| 2023 Q4 | REDUCED | 79,851 | -604 | -0.8% | 0.00% | $787K | $9.86 |
| 2023 Q3 | REDUCED | 80,455 | -50,575 | -38.6% | 0.00% | $615K | $7.65 |
| 2023 Q2 | REDUCED | 131,030 | -61,126 | -31.8% | 0.00% | $979K | $7.47 |
As of 2025 Q4 — sorted by position size